$1.57
0.031.95%
Last update: Oct 26, 4:27 PM
Skye Bioscience Inc (SKYE) Stock Price, Quote, News & History
SKYENASDAQ
Skye Bioscience reports Phase 2a data showing nimacimab plus semaglutide led to over 22% weight loss at 52 weeks, with lower weight regain and no serious safety...
You can purchase shares of Skye Bioscience (NASDAQ:SKYE) through any online brokerage.
Other companies in Skye Bioscience’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Skye Bioscience has a consensus price target of $136.00.
The stock price for Skye Bioscience (NASDAQ: SKYE) is $1.57 last updated October 26, 2026 at 4:27 PM EDT.
There are no upcoming dividends for Skye Bioscience.
Skye Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Skye Bioscience.
Skye Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by...
